-
Subscribe
for Free
-
-
Our
Cities▾
-
Tech
Channels ▾
-
Meet the
Xconomists ▾
-
Co-Founder, Hunch and Founder Collective
-
Professor, Biochemistry and Biophysics, UCSF
-
CTO, U.S. Dept. of Health and Human Services
-
Chairman, CEO, Acucela
-
Meet All the Xconomists ›
-
Co-Founder and CEO, Tableau Software
-
Founder and Co-Chair, Dept. of Bioengineering, Stanford University
-
General Partner, Alloy Ventures
-
Senior Fellow, Kauffman Foundation
-
Our
Events ▾
-
|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Curis Misses Mark in Cancer Drug Trial, Genzyme Re-Elects Full Board, GTC Cuts Jobs, & More Boston-Area Life Sciences News
|
Erin Kutz |
06/18/10 |
Boston
|
|
GTC Axes 50 Workers, CEO Out
|
Luke Timmerman |
06/16/10 |
Boston
|
|
New England Venture Activity Rebounds Slightly in Q2—Region’s Top 10 Deals List
|
Ryan McBride |
07/21/09 |
Boston
|
|
Elixir Sips $12M, Might Eventually Guzzle $500M; Evergreen Solar Offers $60M in Stock; BigBelly Bags $3.2M; & More Boston-Area Deals News
|
Rebecca Zacks |
05/22/09 |
Boston
|
|
Elixir Raises $12 Million, Says Drug Trial Could Lead to Novartis Purchase
|
Roxanne Palmer |
05/19/09 |
Boston
|
|
Elixir Pharmaceuticals Obtains $12,000,000 New Financing
|
VentureDeal |
05/19/09 |
Boston
|
|
The Greater Boston Diabetes Cluster
|
Ryan McBride |
02/09/09 |
Boston
|
|
Accelerator Startup, GPC-Rx, Uses Computers to Make Drugs Without Side Effects
|
Luke Timmerman |
11/21/08 |
Seattle
|
|
RXi Tackles RNAi Delivery, Pfizer Launches A Two-Cambridge Stem Cell Effort, Archemix Plows An Alternative Path to the Public Market, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
11/20/08 |
Boston
|
|
Elixir Reports Positive Results in Late-Stage Clinical Trial for Diabetes Drug
|
Ryan McBride |
11/19/08 |
Boston
|
|
Seattle’s Pharma Godfather, Ben Shapiro, Sees Potential Here To Transform Medicine Despite Setbacks
|
Luke Timmerman |
11/17/08 |
Seattle
|
|
The Boston-Area Obesity Treatment Cluster: Are Flood Gates Opening for Weight-Loss Drugs and Devices?
|
Ryan McBride |
10/08/08 |
Boston
|
|
Elixir Pulls IPO, Mascoma Runs With Marathon, InnoCentive Gets an Incentive, Novartis Ups Alnylam Stake, & More Deals News
|
Rebecca Zacks |
05/12/08 |
Boston
|
|
IPO Market in Tailspin—Pogo Jet Latest to Pull Offering
|
Robert Buderi |
03/18/08 |
Boston
|
|
Sirtris Finds Anti-Cancer Effect, Teams with NIH
|
Wade Roush |
02/22/08 |
Boston
|
|
Athenahealth Pulls Secondary Public Offering; No Jets for the Weary?
|
Robert Buderi |
02/01/08 |
Boston
|
|
Endeca Scores Some Intel Dollars, MIT Teams with ABB, Another IPO Off the List, & More
|
Rebecca Zacks |
01/28/08 |
Boston
|
|
BG Medicine Pulls IPO
|
Rebecca Zacks |
01/24/08 |
Boston
|
|
MIT Teams With Italian Energy Giant, Elixir Postpones Its IPO, Biogen Idec Will Buy or Be Bought, & More
|
Rebecca Zacks |
01/23/08 |
Boston
|
|
Elixir Postpones IPO
|
Rebecca Zacks |
01/17/08 |
Boston
|
|
Glasshouse Plots for VMware IPO Sequel, Idera Partners With Merck, iRobot Inks Deal With Army, & More
|
Rebecca Zacks |
12/24/07 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.